Philip Morris
Fields
- Author
- Greenshields, A.
- Reinhardt, U.
- Area
- NICOLI,DAVID/OFFICE
- Type
- NEWS, NEWS ARTICLE
- Site
- W6
- Request
- Stmn/R1-072
- Stmn/R1-079
- Named Organization
- FDA, Food and Drug Administration
- Health Industry Mfg Assn
- Medtronic
- Minetec
- Novacor
- Pathfinder Venture Capital
- Stanford Univ
- Star Tribune
- Univ of Mn
- American College of Thoracic Surgery Con
- Baxter Healthcare
- Health Industry Mfg Assn
- Named Person
- Adler, S.
- Burlington, B.
- Cosentino, L.
- Greenshields, A.
- Magazine, A.
- Portner, P.
- Stinson, T.
- Burlington, B.
- Document File
- 2046936725/2046937271/Missing
- Litigation
- Stmn/Produced
- Author (Organization)
- Pathfinder Venture Capital
- Princeton Univ
- Master ID
- 2046936726/6992
Related Documents:- 2046936726 Table of Contents
- 2046936727 A
- 2046936728-6731 FDA's Legally Suspect Actions Invite Challenge
- 2046936732-6735 FDA Paralysis Raises Health Care Costs
- 2046936736-6739 the Real Problem with Health Care in America: While Dr. David Kessler's FDA Fiddles, Medical Approvals Lag and Americans Die
- 2046936740-6743 What the FDA Doesn't Want You to Know Could Kill You
- 2046936744-6751
- 2046936752-6759
- 2046936760-6762 Guide to Medical Device Regulation FDA Issues First Warning Letter Citing Gmp Problems Under New Cpg
- 2046936763-6766 the Vitamin Uprising
- 2046936767-6780 Losing the Edge Overseas Patients Reap the Benefits of U.S.Research While Those Here Wait
- 2046936781-6783 Losing the Edge
- 2046936784 Feds: Toughen Regulation, Promote Research Improvements Needed, and They Are on the Way
- 2046936787-6789 Challenging FDA Authority
- 2046936790-6793 Speakeasies in A New Age of Prohibition
- 2046936794-6798 Who Is Happiest Politician in Washington Over Whitewater? Alfonse D'amato - Newt Gingrich - David Kessler?
- 2046936799-6800 Pro-Free Enterprise Group Challenges FDA's Authority to Regulate Drug Companies' Speech
- 2046936801-6802 Wlf Off-Label Use Suit Heats Up
- 2046936803-6805 Just Call Me 'doc'
- 2046936806-6810 Food and Drugs and Politics
- 2046936811-6813 Science and Technology Getting the Lead Out
- 2046936814 Forbes Fear of Falling 5 Ways to Protect Yourself in Scary Times
- 2046936815-6816 Book Burning
- 2046936817 If A Murderer Kills You, It's Homicide If A Drunk Driver Kills You, It's Manslaughter If the FDA Kills You, It's Just Being Cautious
- 2046936818-6820 Frustration for Medical Innovators
- 2046936821 Block That Innovation
- 2046936822-6823 Getting Even
- 2046936824-6826 Biotech Pipeline: Bottleneck Ahead
- 2046936827-6829 Consuming Interest Are We Safe From the FDA?
- 2046936830-6839 Saying Yes to Drugs Policy Analysis
- 2046936840-6858 Deadly Overcaution: FDA's Drug Approval Process
- 2046936859 B
- 2046936860-6861 Litigation Update Wlf Wins Suit Against FDA to Stop Overregulation of Heart Valves (Washington Legal Foundation V. Shalala)
- 2046936862-6863 Litigation Update Wlf Opposes FDA Efforts to Dismiss First Amendment Lawsuit (Washington Legal Foundation V. Kessler)
- 2046936864-6867 Dickinson's FDA Review
- 2046936868-6869 Wlf Urges Appeals Court to Enjoin Federal Policy Restricting Human Heart Valve Transplant (Washington Legal Foundation V. Shalala)
- 2046936870-6871 FDA Problems Slow US Andas
- 2046936872-6873 Taking the Heat An Aids Patient Champions A Risky Blood Treatment Banned in the U.S.
- 2046936874-6876 New Study Says Breast Implants Are Not A Health Risk
- 2046936877-6878 Wlf Sues FDA to Overturn Policy Restricting Information on Off-Labels Uses of Approved Drugs and Devices (Washington Legal Foundation V. Shalala)
- 2046936879 Ex-Inspector of F.D.A. Is Convicted of Bribery
- 2046936879A FDA Has No Position Yet
- 2046936880-6881 M-D-D-I Reports - 'the Gray Sheet'
- 2046936882 FDA Halts Test on Device That Shows Promise for the Victims of Cardiac Arrest
- 2046936883 Law Concerning Medical Devices Is Often Ignored
- 2046936884 Dairies, Drugs and Accusations
- 2046936884A FDA to Launch Campaign on New Labels for Food
- 2046936885 Probe of Three FDA Officials Sought Industry Ties Before Approval of Bovine Growth Hormone Are at Issue
- 2046936886-6889 Safety First How A Device to Aid in Breast Self-Exams If Kept Off the Market Other Nations Approved It But U.S. Demands Proof Simple Pad Isn't Risky Nine Year Battle with the FDA
- 2046936890-6892 Who Will Regulate the Regulators? If You Make A Mistake, Shouldn't You Own Up? Not If You're the FDA, Epa, or Ftc
- 2046936893-6894 None - A - Day Is the FDA Out to Take Your Vitamin?
- 2046936895 Will A New Government Program Net the Bad Fish?
- 2046936896-6897 FDA Responds to Wlf Petition Regarding Off-Label Drug Use by Indefinitely Postponing Issuance of Regulatory Guidelines
- 2046936898-6905 FDA Research: Overview
- 2046936906-6910 Government Report Finds Levels Safe Pesticide Residues in Your Children's Food
- 2046936911-6912 Wlf Urges FDA to Rescind Policy Restricting Information Flow on Off-Label Uses of Approved Drugs and Devices
- 2046936913 Regulatory Chokehold FDA Red Tape Dooms Transplant Drug
- 2046936914 FDA Called Lax in Overseeing Medical Sterilizers, Disinfectants
- 2046936915 FDA Sets Labeling Rules for Dietary Supplements Nutritional Data, Support for Health Claims Required
- 2046936916 Chemicals That Taint Seafood Concerns Continue Over Safety of Methylmercury Inspection Processes
- 2046936917 Lifesaving Devices Languish at the FDA
- 2046936918-6919 Wlf Sues FDA to Enjoin Federal Policy Restricting Human Heart Valve Transplants (Washington Legal Foundation V. Shalala)
- 2046936920 What's in Food? Answers Differ at 2 Agencies Manufacturers Fight to Keep FDA Label Rules From Encroaching on Ftc Ad Rules
- 2046936921 Reform the FDA
- 2046936922 Legal Beat FDA Approval Shield Firms in Injury Suits
- 2046936923 Water From A Bottle
- 2046936924 Commentary FDA and Our Split Medical Persona
- 2046936925-6926 FDA Assailed for Slow Testing of New Drugs
- 2046936927 Andrews Office Products Capitol Heights, Md (K)
- 2046936928-6947 Statement by David A. Kessler, M.D. Commissioner of Food and Drugs Before the Committee on Energy and Commerce Subcommittee on Health and the Environment U.S. House of Representatives
- 2046936948-6961 Filthy Food,Dubious Drugs, and Defective Devices: the Legacy of FDA's Antiquated Statute A Staff Report
- 2046936962-6968 Gao Reports on FDA-Related Topics 860000 to Present
- 2046936969 D
- 2046936970-6985 Statement by Louis W. Sullivan, M.D. Secretary of Health and Human Services Before the Committee on Labor and Human Resources U.S. Senate on the Final Report of the Advisory Committee on the FDA
- 2046936986-6992 Proposed Remarks of Dr. Charles Edwards Before the Senate Committee on Labor and Human Resources
- Characteristic
- ILLE, ILLEGIBLE
- MISS, MISSING PAGES
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- aon65e00
Document Images
' ' t=XpGr ta 0ay L ..., ., .. . _ _
~ partly to blame for industry's dedilne:
Coatlaued troat ps;. l A
Wl= ,re ate dois& acardJaS to
oorposate Ieades sad ecoaomiats, is
slowly souoezias a Ytbssnt in~
witb a oombiaatioa af hesvr
raayl,attoa, beltti;hteaia~ b~~r
bst~aae eurkis and a V.S. tsW
rystca~ tJat p~sssshec ell but a pes>~t
reoattl in a wasld whtre perfection es
~poGil`b1E.
"it deeaa't talce:aush in teUTO of
stncauluion bY tioa or wroat-
huded goliCia b~you lose to
iadttstty," ssia Alaa Ma;azi9e.
~rtsi t of tbe Ha~titA 1~dt~
Ct<irer's tissociattaa, a tmde
;Z+oup sepscse~~ US& compulei;
employsei 350,COi1 wortmm
ia contrast to 8ttsope and Jgm.
wberr braltb iasAtsaae plans oitrn
pty for tee4" protaidn; new
, tbe marlcet tbr new
madus~t deviees in the itaited SIStra
is lisaited Ierfair to FD"pprorec!
tnatments only.
Dr. Stvart A3ler, a Uaiversity of
~ MWaesots ardiolo0t, said iiasast
ewry auh he's on the phcar "oG
uvtuee<tainuy to persuade Medusre
o2dSle to p:Y tor stataokho-an
daSbsilLetors or otiet' deviaa: stilt
e,ottddrr0d experimeatal hete but
widely uwd 3a Etuope or Asia.
"T6o doetor oa the other esd of the
line tat Medieuey wyi, '! sires with
you, Ison with you,ts awith
~ 10 ~vdrds~, "78 t~brroltt~c
we ®taaot pay tor aa iavestiawwoaal
dMioe oad, thllidote, we wost11 pay
To be sure, tbe U.S. iodustty is ettill
~ 8ut g,iowtk rues dre
~tuslly bi;bet overs4u. Aad
taaaY aaaiyits Uy tbu, withottt
pomecion, we Wi113ee a dot:sdnio
dedine withia the aext dcaade. Thc
i~adirs~ this dedi co sra
At ttst atoath's Aatdrieatt C*legc of
'Y'ltorreic 8 rc~mferease io Now
Yerk tb.e,ezlu''an bsIl was
dolQhucd t:y de+ioet aos Yez
CStby s. FDA Eor use ia the
"Unless we do tvmethutt,
~ teahaolop will to eluwbcre. It wili
bc a dirastsr !br tts," st:d Peer
Pormrr, praidwt ofthe Novacor
divstiva of 8axtts Htalth C3ure Cosp.
Rae a Frofe:for at Sttabrd `
Uaivaaisy.
l~aatee c.biefezeeuti
n;va Louu
Cosoatiao batee tha thou~ht of tsra;
F.nr~opeenc atter la~i oj~'
Atneriraas. But vAthout expantiia; ia
Lew, eke itiuresots eosnpiu¢y
eVoY1d lose i teeali Zbitlaa¢ }o ialei +
aad rulc lmiai its rep~uatca a a
lauler in its fiekL ~iimtte canuot
sdotti to E~ead miiliont of doIl~ oa
des,!'is»i, nuildi~ afui test~; nevr
prodects ia the tlaited Ststei astd
Without maldnf s r,ioaic SLk - wait
~n; ts t~Yurs for tpproyatt
Cosc.nttb~iao does not ob'ect to ciaorow
tion. 8ut be
, saoro ti'~ieamid t. ~at A
resulatioa, be said, is icwip;
"In our business, it there
are serious clinlcaW
studies that need to be
done, you go to Europe.
!f someone says they
want to do clinicElS in
U.S., you know they're
out of their minds,"
4'
- Andy 4r*anshl.tdt,
C~, Pathltnder Venture
Is
"You're tuto'ring your
compe#ifors. I never un-
derstood why Americans
do that but that's what
they.do (by investirig in
forelgn reseaxch,, devel-
opment and
manufacturing]."
- uw. ~t.1~t,ard~, .ee~wasYa,
!hlrtosbe ~alwnity
Atasrisaa eetorprisa wbile denying
p bly eitxtiye treataneat to
Padem
Tha 1E'DA wdsY lus a backlaj ot
sotne $,004 produtt eppliptjons.
Not onty does ttA ,FDA k.bp
beiza=
pFroved uCts from
ta tbe rrttsd SsAtes, the ageac~r
~so bars ~epart ot taost ttwplxoved
raedust praiuaia ~cven to
ootwttiat'wlxta the pr+od= bive
IINW app~~ medirsl usa by
L?r. firticx surlin;ton, direotor ofthe
Mi device divis3oo, said tbt
u ttyia; to speed approval
~yatvcuariy kr tlsose devues
thst provide litastvta; tlterepy,.
DwpitE,osoe pro;ress, the wal
:cmetai laaS eaottih fot maar
aomy~uaies to be op~1y 5W&&taCL
Many c=g*aies:ay, ab~ey Ss
practiasliy beiaz iawsted by tbe U.S.
Pvtran3ebt to esetb4ih ti'seiTCJi
eaata~, ~atorfrs aaed diivibttdoc
caate:~c m othat'counffip.
'Wtsst's really imitatia,L me is We'rz
ullaa; about'1ob'st Jobs, jobr' aad
b°" V/Seha~aaa pe~°aa~aS es.rs~aadt jobs
adraaaed m~icetia; jobs," sud
Pt~sbfla~ds~r V"~' ~~
M3aaeaota i"itta thu cpedaLus in
raieiru capital for mem'aL,zae6no~y
~oasas~s. .
Mtmteo i: s easa in t oa= it
cboaris a Dutob ot eI&n loesdoa,
Cosaiaao expects te Vart with 10
eraploYeos snd;tow to abotit SO
wit&ist l S moatbs.
"We wi3t be makiaLand Wroduciag
our ptoduats ottuide the tlnited
Suus before we do anywbha=lure,"
Cneent3ao taid. `Tfl have to pvt
morm ttwao. kitt,ot tba:~r ja~ iato
~urope to prouCS tbe eompaay."
COseatioo`: not tbe oaly oae. The
8tu Tn'buae swv+ey ot Minaeaaca
snerdiul ~deriee malttse fouad
emaspWus tbatsaitea produets Fucb
as hatt pacemAkt'es,lydid:zey dialysis
aQetipsneat aad orthopaedie impiaats
*isidy ara expandiab outside the
uaited Smta, fasoar Wn in
Mitistswts =ad atpeet to set tlte
tsr" aaelr.m in the ttetet five
, y.ars.
More tbaa a tbird of time S 1
WAnufoia IDadi0f,~i ~epstti0i
alwdy We k3Hp+owiat ~pq~tpt~
putsids the vait~d Sute~. 'I'be sutvey
foLttsd 18 ofthue 1wliag-.dpe
r.*mputies hare iarsetamd Wir
yayrollt by d« pesveas in bfimsaats ,
over the last frn yrm, wh3ae
ovescses hirn:i br tbete compaaier
=elted 191 petw=
In tbe nrxt Svs yput, exravtives of
tbaia finsu racp.at taeir Mianewta
P&yroals to eeatiaue tflw ~a
avaap af S2 p.rtrat. uS t~ro
wiasaaac9onsw parratu Rt tizeoe
esae ~to wv 115
alo eapeas ta gmaploy ~o.rem~to~a
~ ca
T,3Q0 employ.s ostti3de tbo tt6tcd
Sutae - up from 407 in 19i9.

MW tsceutim dud a mwte
pvocsbie tqvAstm aliuu tmd
C1C`t to C{3dt!lyt0ii as tlt0 't'o
}YdoGf ft! CiL"iSL7s j.
p4is>j 6+CtO6ti fnd teteiRh
a~atiers tbausradi af mSles fi'om
boeae. Ths stts'Ney LadiGifOd thst
htsltet Pidts oz lowes ooata woce, st
33m; seCaaGbwy Cntitl4rstiQlls 3a
=W=4iag bepnd U.S. borders.
Camfdse Msduoaic, s Mionerars
maw of Ci[di3C pse-li'
cqaipmeat aad hesn vs?ves,At t
~t ~e 6rii i ~14i7 ~ o~t
MysnrirhL tbe xDtbwlswds,
MsAduozio nezt Xtas eupaeta to bsve
` 117 peopis worla~ oe am pre4uww
'iheu tssLies hsvs am.a shoa
harSold ta tb. Lri seren yWs.
May o!' MactQopic't most
i,asavsdvo producti, dtsigaod tv
halp tbe s.te bei~osY ~dcv~elo~pad ia
~m ~~ ca~p ~'sordftrrma
co ovaoamias g+aandAeooa
Ettt+apesa satei now npteseat 34
pen;at oMedzsoafa's savanuea s,ad
Q"Oa'tb ia VJYM bi.t W ovuOppad
ttowtk b the mted Stttrs, flam
T9i3 to t 943, tala zrew sa svenye
27 puneat moslly st Meduaak
~ ISpEWOM erneatLr.S~ana the p"Mrsays
ova the am period.
7li1 quict ttW 7uaoms t,bie rssss's
h4b-tevb dGYicc m,astsafteumr: w
su but aetped pubUe noties. Snt it
distnrbs I;diaapots ezoaoatists.
"if yoa fom tbtm to do the
maatttsoturia~ or tatia~ ouusdc tha
U.~., t~en yott ste~ ~oin so ove~ limt
nsdera~ina tbs bali~l o~t~e doeneuio
iadum," ssid Tota Stiasaa,
W-1101 pU itLtC,CWn083isL
"4bvioatiy, ft's aot s pu2iculittY '
d~raDk positioa tb! thii iadustty,
wbk.h is oas of otu;roash scotoss
sad a ioduetry w1 hope u foia; to
flowEahin e1u 7istceataey.'
0
07
. w
07
~
00
~
